Literature DB >> 30565729

Ailanthone exerts an antitumor function on the development of human lung cancer by upregulating microRNA-195.

Shizhen Hou1, Ziming Cheng1, Wenling Wang1, Xiangdong Wang1, Yubing Wu1.   

Abstract

BACKGROUND: Lung cancer is a common leading cause of cancer-related death worldwide. Ailanthone, a natural compound isolated from Chinese herb Ailanthus altissima, has been reported to exert antiproliferative effects on various cancer cells.
METHODS: The present study aimed to investigate the role of ailanthone in the lung cancer cells and the correlation between the ailanthone and microRNA (miR)-195. The cell viability, proliferation, and apoptosis were determined by cell counting kit-8 assay, bromodeoxyuridine incorporation method, annexin V-fluorescein isothiocyanate/propidium iodide assay, respectively. Apoptosis- and autophagy-related proteins, as well as regulatory factors in the signaling pathways, were analyzed by Western blot method. The expression of miR-195 was quantified by quantitative reverse transcription-polymerase chain reaction.
RESULTS: The results confirmed that ailanthone was involved in the lung cancer cell progress by inhibiting cell viability and proliferation, but promoted cell apoptosis and autophagy. We also found that ailanthone upregulated the expression of miR-195. Further, the downregulated miR-195 inhibited the apoptosis and autophagy induced by ailanthone. Moreover, our studies revealed that miR-195 inhibitor promoted the phosphorylation of PI3K, AKT, JAK, and STAT3, which was inhibited by ailanthone.
CONCLUSION: All these findings suggest that ailanthone plays key roles in lung cancer progress and is closely correlated with miR-195 expression.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  JAK/STAT3; PI3K/AKT; ailanthone; antitumor; lung cancer; miR-195

Mesh:

Substances:

Year:  2018        PMID: 30565729     DOI: 10.1002/jcb.28329

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

Review 1.  Ailanthone: A novel potential drug for treating human cancer.

Authors:  Haixiang Ding; Xiuchong Yu; Chen Hang; Kaijun Gao; Xifeng Lao; Yangtao Jia; Zhilong Yan
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 2.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 3.  The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition.

Authors:  Michael A Serwetnyk; Brian S J Blagg
Journal:  Acta Pharm Sin B       Date:  2020-11-24       Impact factor: 11.413

4.  miR-195 reduces age-related blood-brain barrier leakage caused by thrombospondin-1-mediated selective autophagy.

Authors:  Chien-Yuan Chen; Yung-Mei Chao; Hsiu-Fen Lin; Chao-Jung Chen; Cheng-Sheng Chen; Jenq-Lin Yang; Julie Y H Chan; Suh-Hang H Juo
Journal:  Aging Cell       Date:  2020-10-07       Impact factor: 9.304

5.  Ailanthone suppresses the activity of human colorectal cancer cells through the STAT3 signaling pathway.

Authors:  Haixiang Ding; Xiuchong Yu; Zhilong Yan
Journal:  Int J Mol Med       Date:  2021-12-27       Impact factor: 4.101

6.  Ailanthus Altissima-derived Ailanthone enhances Gastric Cancer Cell Apoptosis by Inducing the Repression of Base Excision Repair by Downregulating p23 Expression.

Authors:  Chun-Ming Wang; Hua-Fu Li; Xiao-Kun Wang; Wu-Guo Li; Qiao Su; Xing Xiao; Teng-Fei Hao; Wei Chen; Ya-Wei Zhang; Hai-Yong Zhang; Wang Wu; Zhen-Ran Hu; Guang-Yin Zhao; Ming-Yu Huo; Yu-Long He; Chang-Hua Zhang
Journal:  Int J Biol Sci       Date:  2021-07-05       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.